Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$76.73 - $120.62 $386,795 - $608,045
-5,041 Reduced 5.53%
86,188 $10.1 Million
Q3 2023

Nov 13, 2023

SELL
$84.17 - $161.17 $329,946 - $631,786
-3,920 Reduced 4.12%
91,229 $8 Million
Q2 2023

Jul 28, 2023

SELL
$155.24 - $196.47 $133,972 - $169,553
-863 Reduced 0.9%
95,149 $15.7 Million
Q1 2023

May 03, 2023

SELL
$146.03 - $184.54 $17,961 - $22,698
-123 Reduced 0.13%
96,012 $17.7 Million
Q4 2022

Jan 24, 2023

BUY
$110.88 - $150.36 $277,310 - $376,050
2,501 Added 2.67%
96,135 $14.2 Million
Q3 2022

Oct 27, 2022

BUY
$125.58 - $169.38 $522,663 - $704,959
4,162 Added 4.65%
93,634 $13.2 Million
Q2 2022

Aug 08, 2022

SELL
$112.97 - $151.71 $1.21 Million - $1.62 Million
-10,702 Reduced 10.68%
89,472 $11.7 Million
Q1 2022

May 05, 2022

BUY
$135.71 - $284.87 $1.39 Million - $2.92 Million
10,245 Added 11.39%
100,174 $14.6 Million
Q4 2021

Jan 20, 2022

BUY
$266.41 - $303.29 $948,686 - $1.08 Million
3,561 Added 4.12%
89,929 $26.3 Million
Q3 2021

Oct 19, 2021

BUY
$249.0 - $285.24 $2.25 Million - $2.58 Million
9,040 Added 11.69%
86,368 $23.4 Million
Q2 2021

Aug 02, 2021

BUY
$208.49 - $248.2 $1.92 Million - $2.29 Million
9,230 Added 13.55%
77,328 $18.7 Million
Q1 2021

May 06, 2021

BUY
$220.31 - $283.75 $8.09 Million - $10.4 Million
36,731 Added 117.1%
68,098 $15.6 Million
Q4 2020

Feb 10, 2021

BUY
$223.82 - $271.35 $3.97 Million - $4.81 Million
17,731 Added 130.03%
31,367 $8.42 Million
Q3 2020

Nov 12, 2020

BUY
$209.49 - $246.81 $2.58 Million - $3.04 Million
12,325 Added 940.12%
13,636 $3.22 Million
Q2 2020

Aug 12, 2020

BUY
$178.49 - $250.39 $155,821 - $218,590
873 Added 199.32%
1,311 $299,000
Q3 2019

Nov 07, 2019

BUY
$145.61 - $159.87 $63,777 - $70,023
438 New
438 $65,000

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $9.05B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.